PTK2 and hepatocellular carcinoma: Additionally, FAK is up-regulated in a wide variety of solid cancers (such as head, oral, breast, neck, bladder, colorectal, lung, thyroid, prostatic, hepatocellular carcinomas) and also melanoma, osteosarcoma and glioblastoma [14].